Changeflow GovPing Pharma & Drug Safety ChangeBridge: Patent Apps - Pharma (A61K)
Favicon for changeflow.com

ChangeBridge: Patent Apps - Pharma (A61K)

RSS

Thursday, March 26, 2026

Favicon for changeflow.com

USPTO Patent Application: Oral Care Compositions

The USPTO has published a new patent application from Colgate-Palmolive Company for oral care compositions containing amino acids and flavor components. The application details methods of making and using these stabilized compositions, aiming to combine traditionally incompatible ingredients.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

USPTO Patent Application for Skin Care Formulations

The USPTO has published a patent application (US20260083651A1) for skin care formulations. The application details a method of treating skin and a topical composition including various extracts and active ingredients. The filing date for this application was December 4, 2025.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

USPTO Patent Application for Renewable Ester Emollient

The USPTO has published a patent application (US20260083652A1) for a renewable ester emollient for enhanced cutaneous permeation, assigned to Oxiteno S.A. Indústria e Comércio. The application details a personal care formulation and a method for moisturizing skin or hair using this emollient.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

USPTO Patent Application: Tooth Whitening Preparation System

The USPTO has published a patent application (US20260083653A1) for a tooth whitening preparation system and method filed by Cobea AG. The application describes a component system including an active ingredient component and an activation component designed to adjust the pH for a physiologically acceptable tooth whitening preparation.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

USPTO Patent Application for Photoprotective System

The USPTO has published a patent application (US20260083654A1) for a photoprotective system consisting of four specific sunscreens, assigned to PIERRE FABRE DERMO-COSMETIQUE. The application details a cosmetic or pharmaceutical composition with a photoprotective system representing 4% to 20% by weight.

Routine Notice Pharmaceuticals

Monday, March 23, 2026

Favicon for changeflow.com

USPTO Patent Application: Sjögren's Syndrome Detection and Treatment

The USPTO has published a patent application detailing methods for detecting and treating Sjögren's syndrome using salivary exosomes. The application, filed by inventors from various institutions, outlines novel diagnostic and therapeutic approaches for the autoimmune disease.

Routine Notice Healthcare
Favicon for changeflow.com

USPTO Patent Application: Pyramidal Meditation Structure Device

The USPTO has published a patent application for a pyramidal meditation structure device. The application, filed by Rein Daloul, describes a structure with vertical beams, walls, an entrance, and integrated pipes with crystals intended to impart healing energy during meditation.

Routine Notice Healthcare
Favicon for changeflow.com

USPTO Patent Application: T cell isolation methods

The USPTO has published patent application US20260079159A1 detailing methods for isolating and expanding specific types of T cells (CD127lo/− regulatory T cells) for potential use in treating immune system disorders. The application was filed on September 12, 2025.

Routine Notice Healthcare
Favicon for changeflow.com

USPTO Patent Application: HRD Cancer Classification and Treatment

The USPTO has published a patent application from Foundation Medicine, Inc. detailing systems and methods for classifying and treating homologous repair deficiency (HRD) cancers. The application describes models for identifying HRD-positive tumors and suggests combination therapies, such as FOLFIRINOX, for treatment.

Routine Notice Healthcare
Favicon for changeflow.com

USPTO Patent Application: Predicting Disease State by Analyzing cfDNA Fragments

The USPTO has published a patent application (US20260080975A1) filed by Foundation Medicine, Inc. The application describes methods for predicting disease states by analyzing cell-free DNA (cfDNA) fragments. This is a routine publication of a patent application.

Routine Notice Healthcare

Showing 111–120 of 120 changes

1 10 11 12

Get ChangeBridge: Patent Apps - Pharma (A61K) alerts

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.